Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility after Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016

  1. Perez Valero, I.
  2. Cabello, A.
  3. Ryan, P.
  4. De La Fuente-Moral, S.
  5. Santos, I.
  6. Vivancos, M.J.
  7. Gonzalez, A.
  8. Gorgolas, M.
  9. Cuevas, G.
  10. Diaz De Santiago, A.
  11. Cano, J.
  12. Rua, G.
  13. Yllescas, M.
  14. González García, J.J.
Journal:
Open Forum Infectious Diseases

ISSN: 2328-8957

Year of publication: 2020

Volume: 7

Issue: 12

Type: Article

DOI: 10.1093/OFID/OFAA482 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus